Results

• All
• Video
• Audio
• Images

• Most recent

1–3 of 3 results for PRISM

• 

  Interim Results of the Phase 1-2 PRISM Trial Evaluating 4D-150 a Dual-Transgene Intravitreal Genetic Medicine for Neovascular (Wet) Age-Related Macular Degeneration

  Christine Kay, MD

  Annual Meeting Talks

  2023

• 

  Phase 2 Population Extension Cohort in the PRISM Trial Evaluating 4D-150 in Adults With Neovascular Age-related Macular Degeneration

  Raj K. Maturi, MD

  Annual Meeting Talks

  2024

• 

  PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults With Neovascular Age-Related Macular Degeneration: 52-Week Results

  John A. Wells, MD, FACS

  Updates from the Field

  2025